•  
  •  
  •  
  •  

2026-05-24 04:14:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores

Keywords Selected:  Unit4

Stock Report

  • NHPC declares CoD of Unit 4 of Subansiri Lower HE Project
  • Completion of US-FDA Inspection at Unit-IV, Tarapur of Aarti Pharmalabs Limited
  • Unit-IV of APL Healthcare Ltd classified as VAI by the US FDA
  • APL Healthcare Ltd's Unit-4 gets 5 observations from USFDA
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Unimech Aerospace commissions two new manufacturing facilities at Bengaluru, KIADB Park
  • Kronox Lab Sciences Ltd receives statutory approvals for Unit 4 at Dahej
  • Fire Incident at APL Healthcare Ltd's Unit 4 at Naidupeta
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • NHPC Ltd completes trial run of Unit 4 of Parbati-II HE project
  • Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana.
  • APL Healthcare Ltd updates on inspection
  • Shilpa Medicare Ltd updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
  • Aurobindo Pharma Ltd receives EIR from USFDA classifying Unit IV as 'Voluntary Action Indicated'
  • Shilpa Medicare Ltd, Unit IV, Jadcherla, Telangana has cleared TGA, Australia GMP inspection
  • Shilpa Medicare Ltd's Unit IV, Jadcherla, Telangana facility has received Health Canada GMP Approval
  • NTPC Ltd commissions Unit 4 of Nabinagar Thermal Power Project
  • Heranba Industries commences Commercial Production at its new Unit-IV

Latest Post

  • Prithvi Exchange India Ltd announces financial performance for the 4th quarter ended March 31, 2026
  • SMS Pharmaceuticals Reports Robust FY26 Performance: PAT Soars 48% and EBITDA Margins Expand to 19%
  • NBCC India Ltd secures 2 orders worth Rs. 42.55 crores
  • Icon Facilitators Limited receives order worth Rs. 2.69 crore
  • Fabtech Technologies Cleanrooms Ltd receives order worth Rs. 65.10 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025